2009Journal of North Sichuan Medical CollegeRequires access

Comparison of Aripiprazole and Risperidone in the Treatment of Female Schizophrenia

Xiaoli Hu

Open publisher page 2 citations

Abstract

Objective To compare the clinical and safety between aripiprazole and risperidone in the treatment of female patients with schizophrenia.Methods 80 female patients with schizophrenia were randomly divided into aripiprazole group and risperidone group for 8 weeks.PANSS and TESS were used to evaluate the efficacy and adverse.Results There was a similar efficacy between the two groups,group of aripiprazole had fewer or slighter side effects.Conclusion The effects of aripiprazole to endocrine and weight were smaller than those of risperidone.Aripiprazole is a safe and effective antipsychotics with good compliance.

About this research paper

What this paper is about

Objective To compare the clinical and safety between aripiprazole and risperidone in the treatment of female patients with schizophrenia.Methods 80 female patients with schizophrenia were randomly divided into aripiprazole group and risperidone group for 8 weeks.PANSS and TESS were used to evaluate the efficacy and adverse.Results There was a similar efficacy between the two groups,group of aripiprazole had fewer or slighter side effects.Conclusion The effects of aripiprazole to endocrine and weight were smaller than those of risperidone.Aripiprazole is a safe and effective antipsychotics with good compliance.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the clinical and safety between aripiprazole and risperidone in the treatment of female patients with schizophrenia.Methods 80 female patients with schizophrenia were randomly divided into aripiprazole group and risperidone group for 8 weeks.PANSS and TESS were used to evaluate the efficacy and adverse.Results There was a similar efficacy between the two groups,group of aripiprazole had fewer or slighter side effects.Conclusion The effects of aripiprazole to endocrine and weight were smaller than those of risperidone.Aripiprazole is a safe and effective antipsychotics with good compliance.

Key concepts: Aripiprazole, Risperidone, Schizophrenia (object-oriented programming), Medicine, Adverse effect, Internal medicine, Psychiatry, Psychology

Related papers

Back to paper searchBrowse research topicsOriginal source
Comparison of Aripiprazole and Risperidone in the Treatment of Female Schizophrenia — Research Paper | ScholarLens